This study indicated the IH-induced upregulation of PYY, GLP-1, and NTS mRNA levels in enteroendocrine cells, implying that the appetite of patients with SAS could be decreased even via the ENS [42]. The gene discussed is PYY; the disease is SATB2 associated disorder.